|
ZNF77 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.247620E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.638790E-03 |
| Normal-vs-Stage2 |
1.126160E-02 |
| Normal-vs-Stage3 |
1.0856000000059E-06 |
| Normal-vs-Stage4 |
8.834200E-04 |
| Stage1-vs-Stage2 |
8.658400E-01 |
| Stage1-vs-Stage3 |
3.575100E-04 |
| Stage1-vs-Stage4 |
1.955010E-01 |
| Stage2-vs-Stage3 |
4.389800E-02 |
| Stage2-vs-Stage4 |
4.064000E-01 |
| Stage3-vs-Stage4 |
4.386000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.26489999999902E-05 |
| Normal-vs-AfricanAmerican |
1.696040E-02 |
| Normal-vs-Asian |
2.135600E-01 |
| Caucasian-vs-AfricanAmerican |
1.738970E-01 |
| Caucasian-vs-Asian |
8.367000E-01 |
| AfricanAmerican-vs-Asian |
7.233800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.044970E-04 |
| Normal-vs-Female |
5.028100E-04 |
| Male-vs-Female |
5.178200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.240100E-03 |
| Normal-vs-Age(41-60Yrs) |
4.032500E-04 |
| Normal-vs-Age(61-80Yrs) |
4.04080000000473E-05 |
| Normal-vs-Age(81-100Yrs) |
2.116000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.294400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.854000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.319400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.168610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.158400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.009000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.733800E-01 |
| Normal-vs-Grade 2 |
2.618400E-03 |
| Normal-vs-Grade 3 |
1.50440999999724E-05 |
| Normal-vs-Grade 4 |
2.588600E-04 |
| Grade 1-vs-Grade 2 |
1.114620E-01 |
| Grade 1-vs-Grade 3 |
3.116600E-03 |
| Grade 1-vs-Grade 4 |
7.822300E-03 |
| Grade 2-vs-Grade 3 |
2.196300E-03 |
| Grade 2-vs-Grade 4 |
5.617700E-02 |
| Grade 3-vs-Grade 4 |
6.062600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.823800E-03 |
| Normal-vs-ccB subtype |
2.02870000000077E-05 |
| ccA subtype-vs-ccB subtype |
6.882600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.210880E-04 |
| Normal-vs-N1 |
3.66500000004155E-06 |
| N0-vs-N1 |
7.856000E-03 |
|
|
